Research, IP Theft & Data Breaches: The Top Cyber Threats Facing Biotech Firms

Biotechnology companies operate at the intersection of scientific research, intellectual property, healthcare, and technology. From genomic data and clinical trial information to proprietary formulas and research findings, biotech firms can maintain vast amounts of valuable digital information. That makes cybersecurity an important consideration for companies working to protect their research and maintain business continuity.

For biotech firms in Massachusetts and beyond, understanding potential cyber threats can be an important part of managing business risk. Cyber Insurance may also be worth considering as part of a broader approach to risk management. Norwood Insurance Agency can help biotech businesses explore insurance considerations that align with their operations, technology, and potential exposures.

Why Are Biotech Companies Attractive Targets For Cybercriminals?

Biotech firms can possess information that has significant financial, scientific, or competitive value. Research data, intellectual property, patient information, proprietary processes, and information about products still under development can all make a company an appealing target.

Unlike some businesses that primarily store financial or customer records, biotechnology companies may manage highly specialized information that took years and substantial investment to develop. A cyber incident involving that information could potentially create operational, financial, legal, and reputational concerns.

Smaller and emerging biotech companies may face additional challenges. They may rely heavily on cloud platforms, third-party laboratories, research partners, and specialized software while operating with lean internal IT teams. These interconnected systems can create additional points of exposure that businesses may need to evaluate.

How Can Research Data Become A Cybersecurity Risk?

Research is often one of a biotech company's most valuable assets. Data from laboratory experiments, clinical studies, drug development, genetic research, and testing can represent years of work and considerable investment.

A cybercriminal who gains unauthorized access to research systems could potentially copy, alter, encrypt, or delete valuable information. Even when data is not stolen, an incident that disrupts access to critical research files could interfere with ongoing projects and deadlines.

Biotech companies can consider implementing safeguards such as access controls, multifactor authentication, employee security training, network monitoring, and regular data backups. Reviewing who has access to sensitive research and why they need that access can also be an important part of an organization's cybersecurity strategy.

How Does Intellectual Property Theft Affect Biotech Firms?

Intellectual property can be central to a biotechnology company's competitive position. Patents, formulas, discoveries, laboratory processes, source code, trade secrets, and unpublished research may all represent valuable company assets.

IP theft can occur through several avenues. External attackers may attempt to access company networks, while insiders or compromised employee accounts can create another potential vulnerability. Third-party vendors, contractors, research institutions, and other business partners may also have access to certain systems or information.

For Massachusetts biotech companies competing in a research-intensive marketplace, protecting intellectual property can be particularly important. Strong cybersecurity practices can complement legal protections and internal policies designed to safeguard proprietary information.

Why Are Data Breaches A Major Concern For Biotechnology Businesses?

Data breaches can involve more than stolen passwords or financial information. Depending on a company's activities, biotech firms may handle employee records, customer information, clinical trial data, health-related information, or other sensitive records.

A breach can create multiple layers of potential consequences. A business may need to investigate what happened, determine which information was affected, notify appropriate parties, work with cybersecurity professionals, and address possible legal or regulatory considerations.

The potential impact can vary significantly depending on the size of the incident and the type of information involved. Cyber Insurance is one risk management option businesses may explore when evaluating how they could respond financially to certain cyber-related incidents, subject to the terms, conditions, exclusions, and limits of a specific policy.

What Other Cyber Threats Should Biotech Companies Watch?

Research theft and data breaches are important concerns, but they are not the only cyber risks biotech firms may encounter. Common attack methods can include phishing, ransomware, credential theft, business email compromise, and social engineering.

Ransomware, for example, can disrupt access to essential systems and files. Phishing attacks may trick employees into providing login credentials or opening malicious attachments. Business email compromise can involve fraudulent requests that appear to come from executives, vendors, or other trusted contacts.

Third-party risk also deserves attention. Biotech companies frequently collaborate with laboratories, manufacturers, consultants, technology providers, universities, and other organizations. A security issue involving one of these partners could potentially affect connected systems or shared information.

How Can Cyber Insurance Fit Into A Biotech Risk Management Strategy?

Cybersecurity controls are an important first line of defense, but businesses may also consider how they would respond financially after a cyber incident. Cyber Insurance can be designed to address certain cyber-related risks, depending on the policy.

Potential considerations can include expenses associated with investigating an incident, responding to affected parties, restoring systems, or addressing certain claims. Some policies may also provide access to specialized resources that can be valuable during a cyber event.

For biotechnology businesses, the right approach can depend on factors such as company size, data collected, technology infrastructure, research activities, contractual obligations, and reliance on third-party providers. Coverage availability, limits, exclusions, and policy conditions can vary, so reviewing these details with an insurance professional can be useful.

What Should Biotech Firms Consider When Reviewing Insurance?

Insurance planning for a biotech company can require a broader perspective than simply selecting a standard business policy. The company's research, technology, property, employees, contracts, and data practices can all influence its risk profile.

Insurance for BioTech Companies may involve evaluating multiple areas of exposure alongside Cyber Insurance. A company may want to review how its insurance program addresses its physical assets, liability exposures, professional services, technology risks, and other operational concerns.

Norwood Insurance Agency works with businesses in Massachusetts and can help companies review their insurance needs as their operations evolve. A growing biotech firm may face different risks after adding employees, expanding research programs, entering new contracts, adopting new technology, or working with additional partners.

How Can Norwood Insurance Agency Help Biotech Companies Prepare?

Cyber threats can change as quickly as biotechnology businesses develop new products, technologies, and research capabilities. Regularly reviewing cybersecurity practices and insurance considerations can give business owners an opportunity to identify potential gaps and make informed decisions.

For Massachusetts biotech firms, Norwood Insurance Agency can provide guidance when evaluating Insurance for BioTech Companies and Cyber Insurance as part of a broader risk management strategy. The goal is to understand the company's unique exposures and explore insurance options that may align with its operations.

Contact Norwood Insurance Agency to discuss your biotechnology company's insurance needs and learn more about options for managing cyber and business risks.